Wu, Guohong Albert; Sugimoto, Chikatoshi; Kinjo, Hideyasu; Asama, Chika; Mitsube, Fumimasa; Talon, Manuel; Gmitter, Frederick G, Jr; Rokhsar, Daniel S (2021). “Diversification of mandarin citrus by hybrid speciation and apomixis”. Nature Communications12: 4377. doi:10.1038/s41467-021-24653-0. and Supplement
Yoshimizu N, Otani Y, Saikawa Y, Kubota T, Yoshida M, Furukawa T, Kumai K, Kameyama K, Fujii M, Yano M, Sato T, Ito A, Kitajima M (2004). “Anti-tumour effects of nobiletin, a citrus flavonoid, on gastric cancer include: antiproliferative effects, induction of apoptosis and cell cycle deregulation”. Aliment Pharmacol Ther1: 95-101. doi:10.1111/j.1365-2036.2004.02082.x. PMID15298613.
Minagawa A, Otani Y, Kubota T, Wada N, Furukawa T, Kumai K, Kameyama K, Okada Y, Fujii M, Yano M, Sato T, Ito A, Kitajima M (2001). “The citrus flavonoid, nobiletin, inhibits peritoneal dissemination of human gastric carcinoma in SCID mice”. Jpn J Cancer Res92 (12): 1322-1328. PMID11749698.
Sato T, Koike L, Miyata Y, Hirata M, Mimaki Y, Sashida Y, Yano M, Ito A. (2002). “Inhibition of activator protein-1 binding activity and phosphatidylinositol 3-kinase pathway by nobiletin, a polymethoxy flavonoid, results in augmentation of tissue inhibitor of metalloproteinases-1 production and suppression of production of matrix metalloproteinases-1 and -9 in human fibrosarcoma HT-1080 cells”. Cancer Res62 (4): 1025-1029. PMID11861377.
Yoshimizu N, Otani Y, Saikawa Y, Kubota T, Yoshida M, Furukawa T, Kumai K, Kameyama K, Fujii M, Yano M, Sato T, Ito A, Kitajima M (2004). “Anti-tumour effects of nobiletin, a citrus flavonoid, on gastric cancer include: antiproliferative effects, induction of apoptosis and cell cycle deregulation”. Aliment Pharmacol Ther1: 95-101. doi:10.1111/j.1365-2036.2004.02082.x. PMID15298613.
